Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2025-12-25 @ 3:46 AM
NCT ID: NCT06908902
Eligibility Criteria: Inclusion Criteria: * Imaging examination confirms a T1 renal tumor (including T1a and T1b), and the investigator deems partial nephrectomy to be beneficial. * Age ranges from 18 to 90 years. * No history of severe kidney disease or autoimmune disorders. * Cardiopulmonary function indicates the ability to tolerate major abdominal surgery. * ECOG performance status score is 0 or 1. * Willingness to undergo zero-ischemia partial nephrectomy and able to provide written informed consent, understanding and agreeing to comply with the study requirements and evaluation schedule. Exclusion Criteria: * Imaging assessment shows a tumor stage of ≥T2. * Imaging indicates that the tumor is located in the renal pelvis or is a Wilms' tumor, etc. * The investigator considers the patient unsuitable for partial nephrectomy. * Major surgery or significant trauma occurred within 28 days prior to enrollment. * Live vaccine received within 28 days prior to enrollment. * Severe chronic or active infections requiring systemic antibacterial, antifungal, or antiviral treatment occurred within 14 days prior to enrollment. * Any traditional Chinese medicine or herbal supplements for cancer treatment taken within 14 days prior to enrollment. * Participation in any other clinical trials.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 80 Years
Study: NCT06908902
Study Brief:
Protocol Section: NCT06908902